FDA Seeks Meeting With Sanofi Executives After Warning on Plants

Inspectors found “significant objectionable conditions” at Sanofi vaccine plants in Canada and France, the U.S. Food and Drug Administration said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.